跳至主要内容
临床试验/NL-OMON49634
NL-OMON49634已完成不适用

Measuring Athletes* Risk of Cardiovascular Events - Exercise-Induced Cardiac Troponin Release and Coronary Atherosclerosis in Amateur Athletes - MARC-EXERSCIENCE

Radboud Universitair Medisch Centrum0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Participation in MARC-2 study (so recent information about coronary
  • atherosclerosis is known).
  • - Availability of recent (<2 years) contrast enhanced coronary CT-scan data
  • - Willingness to be approached for participation in future research (as
  • indicated on the informed consent form of the MARC-2 study)
  • - Able to perform a ±1.5 hour exercise test on a bicycle

排除标准

  • - Unable to give informed consent
  • - Presence of a stent in any coronary artery or undergone coronary artery
  • bypass surgery
  • - Not cleared for exercise training by a cardiologist following the MARC-2
  • study coronary CT-scan findings
  • - Absolute contra-indications for an exercise test (as indicated by the
  • Standard Operating Procedure guidelines of the department of Physiology (see
  • page 16 of C1 protocol)).
  • - Participation in an interventional study targeting cardiovascular health

研究者

相似试验

招募中
不适用
Measuring Athletes’ Risk of Cardiovascular Events - Exercise-Induced Cardiac Troponin Release and CoronaryAtherosclerosis in Amateur Athletes
NL-OMON24615Department of Physiology, Radboudumc60
招募中
不适用
Measuring Athlete's Risk of Cardiovascular eventscoronary artery disease1001108210003216atherosclerosis
NL-OMON35520Meander Medisch Centrum300
尚未招募
不适用
Assessment of cardio vascular risk by measurement of carotid intima-media thickness (cIMT) in adult type I Gaucher disease patients.Gaucher disease type Iglucocerebrosidase deficiency10027424
NL-OMON29706Academisch Medisch Centrum140
进行中(未招募)
1 期
Study to Determine if The Cardiovascular risk indices in Impaired Glucose Tolerance are similar for Polycystic Ovarian Syndrome, and whether they may be modified by Therapy - Cardiovascular risk in PCOS as compared to impaired glucose toleranceThis is a randomised parallel controlled trial between patients with impaired glucose tolerance and those with polycystic ovarian syndrome. Patients will either be randomised to metformin or Pioglitazone.
EUCTR2005-000435-18-GBniversity of Hull48
进行中(未招募)
1 期
Study to Determine if The Cardiovascular risk indices in Type 2 diabetes are similar for Polycystic Ovarian Syndrome, and whether they may be modified by Therapy - Cardiovascular risk in PCOS as compared to type 2 DiabetesThis is a randomised parallel controlled trial between patients with type 2 diabetes and those with polycystic ovarian syndrome. Patients will either be randomised to metformin or Pioglitazone.
EUCTR2005-000461-18-GBniversity of Hull48
Measuring Athletes* Risk of Cardiovascular Events -... | 临床试验